Maternal RSV vaccines reduce Baby Hospitalizations by up to 80 percent

Gavi reports that babies in early-adopting countries have faced fewer hospitalizations after their mothers received respiratory syncytial virus (RSV) vaccines.

Real-world evidence collected three years after the initial rollout of these vaccines shows a substantial impact on infant health. Data from countries that first introduced the maternal RSV vaccination suggest that babies whose mothers received the shot have a 70 to 80 percent lower risk of being hospitalized with the virus compared to babies whose mothers did not.

National studies also record a substantial drop in hospital admissions since these vaccination programs began.